Botulinum Toxin Type A in the Treatment of Chronic Anal Fissure

Conditions: Chronic Anal Fissure

Sex: All

Ages: 18 Years – 70 Years

Phase: NA

Enrollment: 140

Sponsor: State Scientific Centre of Coloproctology, Russian Federation

Location: Russian Federation

Summary

This study is aimed at studying the effectiveness and safety of surgical treatment of chronic anal fissure.

Eligibility Criteria

Inclusion Criteria:Patients with chronic anal fissure with spasm of anal sphincterExclusion Criteria:Inflammatory diseases of the colonPectenosisPrevious surgical interventions on the anal canalIV grade internal and external hemorrhoidsRectal fistulaSevere somatic diseases at the decompensation stagePregnancy and lactationAnal sphincter insufficiencyChronic paraproctitisFibrous polyp of the anal canal, accompanied by clinical manifestationsIndividual intolerance and hypersensitivity to botulinum toxinMyasthenia gravis and myasthenic syndromes

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05598164). StuddyBuddy aggregates publicly available trial information.